Founded Year
1987Stage
PIPE - II | IPOMissing: Glycomed's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Glycomed's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Glycomed Patents
Glycomed has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/30/2002 | 1/20/2009 | Solanum, Vegetable oils, EC 3.2.1, Plant toxins, Fatty acids | Grant |
Application Date | 9/30/2002 |
|---|---|
Grant Date | 1/20/2009 |
Title | |
Related Topics | Solanum, Vegetable oils, EC 3.2.1, Plant toxins, Fatty acids |
Status | Grant |
Glycomed Frequently Asked Questions (FAQ)
When was Glycomed founded?
Glycomed was founded in 1987.
Where is Glycomed's headquarters?
Glycomed's headquarters is located at 11085 North Torrey Pines Road, La Jolla.
What is Glycomed's latest funding round?
Glycomed's latest funding round is PIPE - II.
Who are the investors of Glycomed?
Investors of Glycomed include Point72 Asset Management, Adage Capital Management, OrbiMed Advisors, Acqua Wellington Asset Management, Merlin Biomed Group and 12 more.
Who are Glycomed's competitors?
Competitors of Glycomed include Brain Tunnelgenix Technologies, Acelity, Clarient, Activaero, BioBehavioral Diagnostics Company and 11 more.
Compare Glycomed to Competitors
Rafael Medical has developed a novel anchoring system for safely implanting and retrieving a wide range of intra-vascular devices in a minimally invasive manner. Based on the technology, diagnostic and therapeutic devices can be delivered into small and large blood vessels alike by way of a small-sized delivery system. Following the completion of the SafeFlo Filter the company is now developing additional devices geared to the interventional cardiology market.
Ligon Discovery is a drug discovery company built around the firm's primary technology platform, Small-Molecule Microarrays (SMMs).
ReGear Life Sciences develops and markets products for the sports medicine, physical medicine, and rehabilitation sectors that relieve pain, accelerate recovery, and improve the quality of life. The company's flagship product, the ReBound Therapeutic Warming System, has been cleared for unattended use and aims to deliver innovative deep tissue therapeutic warming through a patented system of comfortable body-part specific garments powered by a portable radio frequency (RF) ReGeneratorTM.
Brain Tunnelgenix Technologies develops medical devices and equipment. It provides non-invasive and continuous wearable technology that tracks human brain temperature through the brain's thermal tunnel. The company was founded in 2006 and is based in Aventura, Florida.
Sensys Medical develops medical diagnostic instruments
CeQur is developing and commercializing advanced yet simple-to-use insulin delivery devices that make it easier for people living with type 2 diabetes to adhere to therapy and stay in control of their disease. The Company's fully optimized device, PaQ, is a three-day, wearable device that provides freedom from multiple daily insulin injections.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.